These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16821762)

  • 1. 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents.
    Nilsson BM
    J Med Chem; 2006 Jul; 49(14):4023-34. PubMed ID: 16821762
    [No Abstract]   [Full Text] [Related]  

  • 2. Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases.
    Wacker DA; Miller KJ
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):438-45. PubMed ID: 18600561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT2C ligands: recent progress.
    Monck NJ; Kennett GA
    Prog Med Chem; 2008; 46():281-390. PubMed ID: 18381128
    [No Abstract]   [Full Text] [Related]  

  • 4. Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents.
    Ahmad S; Ngu K; Miller KJ; Wu G; Hung CP; Malmstrom S; Zhang G; O'Tanyi E; Keim WJ; Cullen MJ; Rohrbach KW; Thomas M; Ung T; Qu Q; Gan J; Narayanan R; Pelleymounter MA; Robl JA
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1128-33. PubMed ID: 20022752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.
    Liu KK; Cornelius P; Patterson TA; Zeng Y; Santucci S; Tomlinson E; Gibbons C; Maurer TS; Marala R; Brown J; Kong JX; Lee E; Werner W; Wenzel Z; Vage C
    Bioorg Med Chem Lett; 2010 Jan; 20(1):266-71. PubMed ID: 19914063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.
    Liu KK; Lefker BA; Dombroski MA; Chiang P; Cornelius P; Patterson TA; Zeng Y; Santucci S; Tomlinson E; Gibbons CP; Marala R; Brown JA; Kong JX; Lee E; Werner W; Wenzel Z; Giragossian C; Chen H; Coffey SB
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2365-9. PubMed ID: 20202843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats.
    Hayashi A; Sonoda R; Kimura Y; Takasu T; Suzuki M; Sasamata M; Miyata K
    Brain Res; 2004 Jun; 1011(2):221-7. PubMed ID: 15157808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists.
    Adams DR; Bentley JM; Benwell KR; Bickerdike MJ; Bodkin CD; Cliffe IA; Dourish CT; George AR; Kennett GA; Knight AR; Malcolm CS; Mansell HL; Misra A; Quirk K; Roffey JR; Vickers SP
    Bioorg Med Chem Lett; 2006 Feb; 16(3):677-80. PubMed ID: 16257207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease.
    Bays HE
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1429-45. PubMed ID: 19900026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.
    Smith BM; Smith JM; Tsai JH; Schultz JA; Gilson CA; Estrada SA; Chen RR; Park DM; Prieto EB; Gallardo CS; Sengupta D; Dosa PI; Covel JA; Ren A; Webb RR; Beeley NR; Martin M; Morgan M; Espitia S; Saldana HR; Bjenning C; Whelan KT; Grottick AJ; Menzaghi F; Thomsen WJ
    J Med Chem; 2008 Jan; 51(2):305-13. PubMed ID: 18095642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor.
    Wacker DA; Varnes JG; Malmstrom SE; Cao X; Hung CP; Ung T; Wu G; Zhang G; Zuvich E; Thomas MA; Keim WJ; Cullen MJ; Rohrbach KW; Qu Q; Narayanan R; Rossi K; Janovitz E; Lehman-McKeeman L; Malley MF; Devenny J; Pelleymounter MA; Miller KJ; Robl JA
    J Med Chem; 2007 Mar; 50(6):1365-79. PubMed ID: 17315987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity.
    Nargund RP; Strack AM; Fong TM
    J Med Chem; 2006 Jul; 49(14):4035-43. PubMed ID: 16821763
    [No Abstract]   [Full Text] [Related]  

  • 13. APD-356 (Arena).
    Jandacek RJ
    Curr Opin Investig Drugs; 2005 Oct; 6(10):1051-6. PubMed ID: 16259227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to antiobesity therapy. An introduction.
    Bishop MJ
    J Med Chem; 2006 Jul; 49(14):3999-4000. PubMed ID: 16821758
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovery and development of 5-HT(₂C) receptor agonists for obesity: is there light at the end of the tunnel?
    Miller KJ; Wacker DA
    Future Med Chem; 2010 Dec; 2(12):1761-75. PubMed ID: 21428799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity.
    Miller KJ
    Mol Interv; 2005 Oct; 5(5):282-91. PubMed ID: 16249524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
    Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACS chemical neuroscience molecule spotlight on Lorcaserin.
    Hopkins CR
    ACS Chem Neurosci; 2010 Nov; 1(11):718-9. PubMed ID: 22778808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential use of selective 5-HT2C agonists in treating obesity.
    Smith BM; Thomsen WJ; Grottick AJ
    Expert Opin Investig Drugs; 2006 Mar; 15(3):257-66. PubMed ID: 16503763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.
    Holenz J; Pauwels PJ; Díaz JL; Mercè R; Codony X; Buschmann H
    Drug Discov Today; 2006 Apr; 11(7-8):283-99. PubMed ID: 16580970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.